This resource provides a clinical overview of anosognosia, a brain-based impairment in self-awareness common in schizophrenia that prevents patients from recognizing their own mental illness. It outlines five critical domains of insight ranging from symptom identification to treatment engagement and highlights how a lack of awareness serves as a primary predictor of medication non-adherence and legal or social crises. To improve outcomes, the guide offers a “Communication Do’s and Don’ts” framework, advocating for empathetic, goal-focused responses and evidence-based interventions like the LEAP method and long-acting antipsychotics to bypass traditional barriers to care.